When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 11 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • increased risk of exposure to HPV
  • immunocompromise
  • sessile exophytic papillomas

Other diagnostic factors

  • asymptomatic
  • pruritus
  • bleeding
  • pain
  • urinary symptoms

Risk factors

  • intercourse at an early age
  • increasing number of lifetime sexual partners
  • young sexually active adults
  • increasing number of partner's lifetime sexual partners
  • immunocompromise

Diagnostic tests

Treatment algorithm

Contributors

Authors

Natalia Mendoza, MD

Pariser Dermatology Specialist

Williamsburg

VA

Disclosures

NM declares that she has no competing interests.

Stephen K. Tyring, MD, PhD, MBA

Clinical Professor

Departments of Dermatology, Microbiology and Molecular Genetics and Internal Medicine

University of Texas Health Science Center

Houston

TX

Disclosures

SKT declares that he has no competing interests.

Acknowledgements

Dr Natalia Mendoza and Dr Stephen K. Tyring would like to gratefully acknowledge Dr Brenda L. Pellicane, a previous contributor to this topic.

Disclosures

BLP declares that she has no competing interests.

Peer reviewers

Angela Moore, MD

Clinical Assistant Professor

University of Texas Medical Branch at Galveston

Galveston

TX

Disclosures

AM declares that she has no competing interests.

Steve Baguley, FRCP, MSc

Consultant Genitourinary Physician

Woolmanhill Hospital

Aberdeen

Scotland

UK

Disclosures

SB declares that he has no competing interests.

Use of this content is subject to our disclaimer